Bryan E. Roberts - 15 Jun 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Reporting relationship: Director
Issuer ticker: TXG
Reported as of: 15 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2022, 17:30:51 UTC
Prior SEC filing: 18 Feb 2022
Next SEC filing: 19 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Bryan E. Roberts

Key filing fact

Bryan E. Roberts filed Form 4 for 10x Genomics, Inc. (TXG) on 17 Jun 2022.

Key facts

This page summarizes Bryan E. Roberts's Form 4 filing for 10x Genomics, Inc. (TXG).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2022, 17:30.

Change

Previous filing in this sequence was filed on 18 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TXG transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +2,120
Change %: +339%
Price: $0.000000
Shares after: 2,745
Date: 15 Jun 2022
Ownership: Direct
Footnotes: F1, F2

TXG holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,037,825
Date: 15 Jun 2022
Ownership: By Funds
Footnotes: F3

TXG holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 411,205
Date: 15 Jun 2022
Ownership: By Trusts
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TXG transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +5,300
Change %
Price: $0.000000
Shares after: 5,300
Date: 15 Jun 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 5,300
Exercise price: $39.62
Footnotes: F2, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Footnote F2

The Reporting Person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the Reporting Person and the Management Company, the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

Footnote F3

Represents (a) 962,309 shares of Class A common stock held by Venrock Associates VI, L.P. ("VA VI") and (b) 75,516 shares of Class A common stock held by Venrock Partners VI, L.P. ("VP VI"). Venrock Management VI, LLC ("VM VI"), is the sole general partner of VA VI. Venrock Partners Management VI, LLC ("VPM VI"), is the sole general partner of VP VI. The Reporting Person is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein.

Footnote F4

These shares are held by trusts for the benefit of the Reporting Person and his family members.

Footnote F5

This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.